Skip to content
lifestyle.forkstofeet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SynAct Pharma
Further Analysis of the Phase 2b ADVANCE Study Reinforces Phase 2b EXPAND Results and Supports Phase 3 Development – FDA Discussions on Trial Design Planned for Q4 2026
September 7, 2026
SynAct Pharma’s CEO and CSO Sell Shares
September 3, 2026
←
Previous Page
1
2